Oleg V. Fatenkov1, Igor L. Davydkin1, Alexander V. Yashkov1, Ekaterina Yu. Gubareva1, Marina V. Komarova1,2 Elena V. Bondarchuk3, Oleg V. Ovchinnikov3, Igor F. Turkanov3, Valery G. Gryaznov3, Aleksey G. Vaganov3, Oleg P. Smoliy3, Alexandr V. Partala3, Olga V. Dolgikh3, Nikolai F. Bunkin4, Valeriy A. Kozlov4, Polina N. Bolotskova4 Alexander S. Dmitriev5, Alexandr A. Semenov6, Grigory A. Flaks3, Aleksandr N. Kosenkov7
1Samara Medical State University, Chapaeyevskaya str. 89, Samara, 443099, Russia
2Samara National Research University, Moskovskoye shosse, 34, Samara, 443086, Russia
3“Concern GRANIT”, Gogolevsky blvd., 31, bldg. 2, Moscow, 119019, Russia
4Bauman Moscow State Technical University, 2-nd Baumanskaya str. 5, Moscow, 105005, Russia
5Kotelnikov Institute of Radio Engineering and Electronics of the Russian Academy of Sciences, Mokhovaya str. 11, bldg.7 Moscow 125009, Russia
6Kotelnikov Institute of Radio Engineering and Electronics of the Russian Academy of Sciences, Mokhovaya str. 11, bldg.7 Moscow 125009, Russia
7N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University); 119992, Trubetskaya str., 8, building 2, Moscow, Russia.
*Corresponding Author: Oleg V Fatenkov, Samara Medical State University, Chapaeyevskaya str. 89, Samara, 443099, Russia.
Received: June 04, 2025; Published: June 30, 2025
The COVID-19 pandemic necessitated innovative approaches for effective treatment and rehabilitation of patients. This study explores the use of pulsed electromagnetic field (PEMF) therapy, traditionally employed in physiotherapy, for clearing the virus from the human oro- and naso-pharynx. This paper reports on a randomized Phase II clinical trial evaluating this approach. In the trial, PEMF therapy was administered for five consecutive days, with a regime of 15-minute exposure followed by 15-minute breaks, totaling at least 4 hours daily. The therapy operated at 50 Hz and 1.5 µT, with peak electrode voltages between 5-6.5 kV and pulse frequencies of 100-150 Hz. The therapy was combined with standard anti-COVID treatment. A total of 236 patients were distributed into three groups: control, PEMF with standard therapy, and deactivated PEMF device with standard therapy. The results were significant: on the 5th day, 87% of patients receiving PEMF tested PCR-negative, compared to 43% in the control group. By day 14, this increased to 99% for the PEMF group, versus 85% in the control group. Notably, no complications or side effects from PEMF exposure were observed. In conclusion, the combination of PEMF therapy with standard COVID-19 treatment significantly accelerated patient recovery, with a high rate of PCR- negative results and no reported side effects. This trial is registered on ClinicalTrials.gov (NCT05220579) and is retrospectively registered.
Keywords: Non-Contact; Remote; Wireless Therapy; Electromagnetic Therapy; Covid-19; Virus; PEMF; EMF
Citation: Oleg V Fatenkov., et al. “Efficacy of a Pulsed Electromagnetic Field in Accelerating COVID-19 Clearance: Phase II Clinical Trial Results”.Acta Scientific Medical Sciences 9.7 (2025): 123-131.
Copyright: © 2025 Oleg V Fatenkov., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.